BCAT-IN-1 is a potent, selective and orally active inhibitor of BCATm , with a pIC 50 of 7.3. BCAT-IN-1 shows 100-fold selectivity for BCATm over BCATc ( pIC 50 =5.4). BCAT-IN-1 can be used for the research of metabolic diseases.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Aminotransferases (Transaminases)
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.